In order to inform patients about their treatment options.

In order to inform patients about their treatment options, ASTRO has an up-to-date brochure that patients use to deal with their healthcare provider when considering radiotherapy speak developed as part of their treatment. The brochure also helps patients find support groups and information about clinical trials.

ASTRO is the largest radiation oncology society in the world to specialize with more than 8,000 members in the treatment of patients with radiation therapies. As the leading organization in radiation oncology, biology and physics, the Society is to promote the practice of radiation oncology by promoting excellence in patient care, providing opportunities for educational and professional development, promoting research and disseminating research results and representing radiation oncology dedicated in a rapidly evolving socioeconomic healthcare.Less than 200.000ion. Granted Orphan Drug Designation replaced of corneal graft rejection from U.S. With FDA.

Over EyeGate pharmaceuticalEyeGate been established in 1998 with technology license of Bascom Palmer Eye Institute of the University of in Miami. EyeGate to transscleral ionophoresis delivery platform that EyeGate II delivery system is designed a wide variety of a wide range of safely therapeutics for the treatment both of the front and rear chambers of the eye. These are some the sickest patients country and generally but not always, a disrupted ability of. MHC – reporting The administration of electro-convulsive therapy in Accepted Centre: annual report 2009).